Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
7.08
+0.22 (3.21%)
At close: Aug 25, 2026, 4:00 PM EDT
7.25
+0.17 (2.40%)
Pre-market: Aug 26, 2026, 4:04 AM EDT
Verastem Market Cap
Verastem has a market cap or net worth of $641.19 million as of August 25, 2026. Its market cap has increased by 14.74% in one year.
Market Cap
641.19M
Enterprise Value
589.17M
1-Year Change
14.74%
Ranking
Category
Stock Price
$7.08
ChartMarket Cap Chart
Since January 27, 2012, Verastem's market cap has increased from $213.30M to $641.19M, an increase of 200.60%. That is a compound annual growth rate of 7.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 641.20M | 24.38% |
| Dec 31, 2025 | 515.50M | 124.03% |
| Dec 31, 2024 | 230.10M | 11.86% |
| Dec 29, 2023 | 205.70M | 143.14% |
| Dec 30, 2022 | 84.60M | -77.35% |
| Dec 31, 2021 | 373.50M | 3.29% |
| Dec 31, 2020 | 361.60M | 263.05% |
| Dec 31, 2019 | 99.60M | -59.81% |
| Dec 31, 2018 | 247.80M | 99.36% |
| Dec 29, 2017 | 124.30M | 200.24% |
| Dec 30, 2016 | 41.40M | -39.74% |
| Dec 31, 2015 | 68.70M | -70.98% |
| Dec 31, 2014 | 236.70M | -19.05% |
| Dec 31, 2013 | 292.40M | 56.53% |
| Dec 31, 2012 | 186.80M | -12.42% |
| Jan 27, 2012 | 213.30M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 646.71M |
| Scribe Therapeutics | 643.84M |
| Autolus Therapeutics | 641.45M |
| CorMedix | 639.14M |
| Sagimet Biosciences | 637.13M |
| MiMedx Group | 631.14M |
| OmniAb | 629.54M |
| Eikon Therapeutics | 616.94M |